Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Vaxcyte
Company

Vaxcyte

Tracked across 1 events · 7 articles · First seen Jan 29, 2026 · Last active Jan 30, 2026

Sentiment
20
Attention
4
Events
1
Relationships
6
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 20
Business
Vaxcyte Prices $550M Public Offering
Vaxcyte has commenced an underwritten public offering of $500 million in common stock and pre-funded warrants, with an option for underwriters to purchase an additional $75 million. This offering is expected to generate $550 million in gross proceeds, strengthening its financial position for vaccine development. The company's stock has shown impressive returns, and analysts maintain a Strong Buy consensus.
Jan 29, 2026 · 7 articles
Relationships (6)
Evercore===Evercore ↔ Vaxcyte Unknown
Sutro Biopharma licensee ↔ Vaxcyte Vaxcyte exclusively licenses its XpressCF platform from Sutro Biopharma.
Guggenheim Partners===Guggenheim Partners ↔ Vaxcyte Unknown
SVB Financial Group===Leerink Partners ↔ Vaxcyte Unknown
Bank of America===Bank of America ↔ Vaxcyte Unknown
Jefferies Financial Group===Jefferies Group ↔ Vaxcyte Unknown
NEWSDESK
Track Vaxcyte live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.